Cargando…

Roles of GRK and PDE4 Activities in the Regulation of β(2) Adrenergic Signaling

An important focus in cell biology is understanding how different feedback mechanisms regulate G protein–coupled receptor systems. Toward this end we investigated the regulation of endogenous β(2) adrenergic receptors (β2ARs) and phosphodiesterases (PDEs) by measuring cAMP signals in single HEK-293...

Descripción completa

Detalles Bibliográficos
Autores principales: Xin, Wenkuan, Tran, Tuan M., Richter, Wito, Clark, Richard B., Rich, Thomas C.
Formato: Texto
Lenguaje:English
Publicado: The Rockefeller University Press 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2279169/
https://www.ncbi.nlm.nih.gov/pubmed/18347080
http://dx.doi.org/10.1085/jgp.200709881
_version_ 1782152067860660224
author Xin, Wenkuan
Tran, Tuan M.
Richter, Wito
Clark, Richard B.
Rich, Thomas C.
author_facet Xin, Wenkuan
Tran, Tuan M.
Richter, Wito
Clark, Richard B.
Rich, Thomas C.
author_sort Xin, Wenkuan
collection PubMed
description An important focus in cell biology is understanding how different feedback mechanisms regulate G protein–coupled receptor systems. Toward this end we investigated the regulation of endogenous β(2) adrenergic receptors (β2ARs) and phosphodiesterases (PDEs) by measuring cAMP signals in single HEK-293 cells. We monitored cAMP signals using genetically encoded cyclic nucleotide-gated (CNG) channels. This high resolution approach allowed us to make several observations. (a) Exposure of cells to 1 μM isoproterenol triggered transient increases in cAMP levels near the plasma membrane. Pretreatment of cells with 10 μM rolipram, a PDE4 inhibitor, prevented the decline in the isoproterenol-induced cAMP signals. (b) 1 μM isoproterenol triggered a sustained, twofold increase in phosphodiesterase type 4 (PDE4) activity. (c) The decline in isoproterenol-dependent cAMP levels was not significantly altered by including 20 nM PKI, a PKA inhibitor, or 3 μM 59-74E, a GRK inhibitor, in the pipette solution; however, the decline in the cAMP levels was prevented when both PKI and 59-74E were included in the pipette solution. (d) After an initial 5-min stimulation with isoproterenol and a 5-min washout, little or no recovery of the signal was observed during a second 5-min stimulation with isoproterenol. (e) The amplitude of the signal in response to the second isoproterenol stimulation was not altered when PKI was included in the pipette solution, but was significantly increased when 59-74E was included. Taken together, these data indicate that either GRK-mediated desensitization of β2ARs or PKA-mediated stimulation of PDE4 activity is sufficient to cause declines in cAMP signals. In addition, the data indicate that GRK-mediated desensitization is primarily responsible for a sustained suppression of β2AR signaling. To better understand the interplay between receptor desensitization and PDE4 activity in controlling cAMP signals, we developed a mathematical model of this system. Simulations of cAMP signals using this model are consistent with the experimental data and demonstrate the importance of receptor levels, receptor desensitization, basal adenylyl cyclase activity, and regulation of PDE activity in controlling cAMP signals, and hence, on the overall sensitivity of the system.
format Text
id pubmed-2279169
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher The Rockefeller University Press
record_format MEDLINE/PubMed
spelling pubmed-22791692008-10-01 Roles of GRK and PDE4 Activities in the Regulation of β(2) Adrenergic Signaling Xin, Wenkuan Tran, Tuan M. Richter, Wito Clark, Richard B. Rich, Thomas C. J Gen Physiol Articles An important focus in cell biology is understanding how different feedback mechanisms regulate G protein–coupled receptor systems. Toward this end we investigated the regulation of endogenous β(2) adrenergic receptors (β2ARs) and phosphodiesterases (PDEs) by measuring cAMP signals in single HEK-293 cells. We monitored cAMP signals using genetically encoded cyclic nucleotide-gated (CNG) channels. This high resolution approach allowed us to make several observations. (a) Exposure of cells to 1 μM isoproterenol triggered transient increases in cAMP levels near the plasma membrane. Pretreatment of cells with 10 μM rolipram, a PDE4 inhibitor, prevented the decline in the isoproterenol-induced cAMP signals. (b) 1 μM isoproterenol triggered a sustained, twofold increase in phosphodiesterase type 4 (PDE4) activity. (c) The decline in isoproterenol-dependent cAMP levels was not significantly altered by including 20 nM PKI, a PKA inhibitor, or 3 μM 59-74E, a GRK inhibitor, in the pipette solution; however, the decline in the cAMP levels was prevented when both PKI and 59-74E were included in the pipette solution. (d) After an initial 5-min stimulation with isoproterenol and a 5-min washout, little or no recovery of the signal was observed during a second 5-min stimulation with isoproterenol. (e) The amplitude of the signal in response to the second isoproterenol stimulation was not altered when PKI was included in the pipette solution, but was significantly increased when 59-74E was included. Taken together, these data indicate that either GRK-mediated desensitization of β2ARs or PKA-mediated stimulation of PDE4 activity is sufficient to cause declines in cAMP signals. In addition, the data indicate that GRK-mediated desensitization is primarily responsible for a sustained suppression of β2AR signaling. To better understand the interplay between receptor desensitization and PDE4 activity in controlling cAMP signals, we developed a mathematical model of this system. Simulations of cAMP signals using this model are consistent with the experimental data and demonstrate the importance of receptor levels, receptor desensitization, basal adenylyl cyclase activity, and regulation of PDE activity in controlling cAMP signals, and hence, on the overall sensitivity of the system. The Rockefeller University Press 2008-04 /pmc/articles/PMC2279169/ /pubmed/18347080 http://dx.doi.org/10.1085/jgp.200709881 Text en Copyright © 2008, The Rockefeller University Press This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/).
spellingShingle Articles
Xin, Wenkuan
Tran, Tuan M.
Richter, Wito
Clark, Richard B.
Rich, Thomas C.
Roles of GRK and PDE4 Activities in the Regulation of β(2) Adrenergic Signaling
title Roles of GRK and PDE4 Activities in the Regulation of β(2) Adrenergic Signaling
title_full Roles of GRK and PDE4 Activities in the Regulation of β(2) Adrenergic Signaling
title_fullStr Roles of GRK and PDE4 Activities in the Regulation of β(2) Adrenergic Signaling
title_full_unstemmed Roles of GRK and PDE4 Activities in the Regulation of β(2) Adrenergic Signaling
title_short Roles of GRK and PDE4 Activities in the Regulation of β(2) Adrenergic Signaling
title_sort roles of grk and pde4 activities in the regulation of β(2) adrenergic signaling
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2279169/
https://www.ncbi.nlm.nih.gov/pubmed/18347080
http://dx.doi.org/10.1085/jgp.200709881
work_keys_str_mv AT xinwenkuan rolesofgrkandpde4activitiesintheregulationofb2adrenergicsignaling
AT trantuanm rolesofgrkandpde4activitiesintheregulationofb2adrenergicsignaling
AT richterwito rolesofgrkandpde4activitiesintheregulationofb2adrenergicsignaling
AT clarkrichardb rolesofgrkandpde4activitiesintheregulationofb2adrenergicsignaling
AT richthomasc rolesofgrkandpde4activitiesintheregulationofb2adrenergicsignaling